In particular, we show for the first time that SOX2 is over-expressed not only in the tumor core but also in the close margin of OSCC patients with advanced tumor stage and lymph node compromise, thus suggesting that high levels of SOX2 may predict for a local spreading. This evidence concerns the gene SOX2 and neoplasm.